Physician

Annie Agbor Arrey Mensah, MD

According to 2025 Medicare claims, Annie Mensah, MD (NPI: 1235174996) practices allergy/immunology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is ASTHMA, ALLERGY & IMMUNOLOGY INSTITUTE, PLC (NPI: 1558481218; TIN: 753231457) and primary practice location at 48034-1045.

Mensah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 45 traditional Medicare patients, billed 2,907 HCPCS/CPT codes, and received $31,211 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 537 prescription claims across 74 beneficiaries totaling $2,896,273 in drug costs, led by Cinryze (C1 Esterase Inhibitor). DME data shows 69 claims. Open Payments data shows 2 records totaling $10,018. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $61,589 to $31,211. Similarly, Part D prescription costs have fallen sharply in recent years, from $1,042,974 to $2,896,273. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,439 to $138.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	52	2,038	$61,589
2016	62	2,586	$87,571
2017	69	3,515	$110,599
2018	79	3,579	$94,058
2019	69	2,242	$69,662
2020	52	1,504	$54,931
2021	68	1,275	$59,804
2022	53	4,871	$103,406
2023	48	996	$18,115
2024	45	2,907	$31,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	53	507	$1,042,974
2016	64	521	$2,972,398
2017	67	750	$5,625,994
2018	80	706	$4,593,885
2019	90	749	$6,092,328
2020	81	780	$6,829,881
2021	89	714	$5,557,238
2022	81	619	$4,313,290
2023	70	497	$2,883,927
2024	74	537	$2,896,273

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	52	$48,148
2016	N/R	60	$67,007
2017	N/R	39	$33,469
2018	N/R	47	$32,809
2019	N/R	36	$31,285
2020	N/R	89	$141,912
2021	N/R	114	$236,532
2022	N/R	94	$215,074
2023	N/R	47	$163,081
2024	N/R	69	$186,151

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	13	13	$173
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	28	52	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	16	23	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	25	47	$13
36415	Insertion of needle into vein for collection of blood sample	19	25	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cinryze	C1 Esterase Inhibitor	24	692	$1,999,913
Haegarda	C1 Esterase Inhibitor	20	600	$566,469
Icatibant	Icatibant Acetate	17	277	$247,587
Dupixent Syringe	Dupilumab	11	308	$40,272
Qvar Redihaler	Beclomethasone Dipropionate	18	1,020	$8,162

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	24	$100,306
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$78,469
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	21	$7,252
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	12	$123

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$10,000	Alexion Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Annie Agbor Arrey Mensah, MD?

Tedicare shows public-source Medicare data for Annie Agbor Arrey Mensah, MD (NPI 1235174996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Annie Agbor Arrey Mensah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Annie Agbor Arrey Mensah, MD?

Annie Agbor Arrey Mensah, MD is linked to ASTHMA, ALLERGY & IMMUNOLOGY INSTITUTE, PLC (billing NPI 1558481218) in the available physician profile data.

Does Annie Agbor Arrey Mensah, MD have Open Payments data?

Annie Agbor Arrey Mensah, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.